CCG-203971
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-108361-100 mg |
| CAS # | 1443437-74-8 |
| Pricing | 100 mg, USD $290.0 |
| Biological Activity | CCG-203971 is a second-generation Rho/MRTF/SRF pathway inhibitor. CCG-203971 potently targets RhoA/C-activated SRE-luciferase (IC50 =6.4 μM). CCG-203971 inhibits PC-3 cell migration with an IC50 of 4.2 μM. Potential anti-metastasis Agent[1][2]. |
| Purity | ≥98.0% |
| MWt | 408.88 |
| Formula | C₂₃H₂₁ClN₂O₃ |